Boston Scientific Corporation (BSX) stock analysis: October 28, 2026

Technical view

• Price ($43.47) gapped down from Tuesday's close ($45.06) and sits below its 21 EMA ($44.42), 50 EMA ($45.10), 100 EMA ($48.22) and 200-day EMA (about $57, from daily closes). The stock is about 59% below its 52-week high of $105.65.
• Q3 sales grew only 1.5% to $5.14B and adjusted EPS was $0.73 (GAAP $0.40), after an August cyberattack disrupted operations. Full-year adjusted EPS guidance is $3.16 to $3.18, and Q4 sales are expected to fall 1% to 3% (Q4 adjusted EPS $0.77 to $0.79).
• Price opened at $41.95, made a new 52-week low of $39.57, then bounced to $43.47, recovering most of the opening gap.
• RSI (14) reads 44.5: neutral to weak. The chart's MACD line (0.08) is below its signal (0.29), and the histogram is negative (-0.21).
• Breadth is mixed: NYSE decliners lead about 1.3 to 1 (1,217 vs 948) while Nasdaq is close to even (1,611 vs 1,527). About 58% of S&P 500 stocks are above their 50-day average and 58% above their 200-day.
• New 52-week lows outnumber highs on both exchanges (NYSE 48 vs 37, Nasdaq 135 vs 60), about 2:07 PM ET.
• Options Swing Helper trend bias: Bearish, HV Rank 23.07% (Cheap): option premium is low for its own past year, with annualized volatility at 27.54%.
• Volume was 41.82M at snapshot time, about 2.3x its 30-day average (17.95M) with the session still open.

Market breadth and new highs / lows

• NYSE: 948 advancers vs 1,217 decliners, about 1.3 to 1 negative. Nasdaq: 1,611 vs 1,527, close to even (midday).
• About 58% of S&P 500 stocks were above their 50-day average and 58% above their 200-day (Barchart, about 12:43 PM ET): participation a little better than half the index.
• New 52-week highs vs lows (Barchart, about 2:07 PM ET): NYSE 37 vs 48, Nasdaq 60 vs 135, so lows lead on both exchanges.

Fundamentals

Sector / Industry

Healthcare / Medical Devices

Analyst Consensus

Buy (30 analysts)

Avg. Price Target

~$57.82 (+33.0%)

P/E (TTM / Fwd)

18.4x / 13.1x

Revenue (TTM)

$21.07B (+8.9% YoY)

Q3 Result

Sales $5.14B (+1.5%); adj. EPS $0.73

Beta

0.58 (less volatile than the market)

Earnings

Reported Oct 28, 2026

Volatility snapshot (Options Swing Helper)

Expected Move (30d)

±$4.13 (±9.50%)

1 SD Range

$39.34 - $47.60

HV Rank (Ann. HV)

23.07% (27.54%)

Premium

Cheap

The expected move and 1 SD range come from the Options Swing Helper indicator on the chart; they describe how far the market is pricing the stock to move over 30 days, not where it will go.